Tarsus Pharmaceuticals (TARS) Earnings Date, Estimates & Call Transcripts $49.44 +0.93 (+1.92%) Closing price 04:00 PM EasternExtended Trading$50.31 +0.87 (+1.77%) As of 07:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Tarsus Pharmaceuticals Earnings Summary Upcoming Earnings DateMay. 6After Market ClosesEstimatedConsensus EPS (Feb. 25) -$0.68 Actual EPS (Feb. 25) -$0.60 Beat By $0.08 Actual Revenue (Feb. 25) $66.41MTarsus Pharmaceuticals issued Q4 2024 earnings on February 25, 2025, reporting an EPS of -$0.60, which beat the consensus estimate of -$0.68 by $0.08. Quarterly revenue was reported to be $66.41 million, above the consensus estimate of $58.80 million. With a trailing EPS of -$3.10, Tarsus Pharmaceuticals' earnings are expected to grow next year, from ($3.17) to ($1.44) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Annual Report (10-K)TARS Upcoming EarningsTarsus Pharmaceuticals' Q1 2025 earnings is scheduled for Tuesday, May 6, 2025, with a conference call scheduled on Wednesday, May 7, 2025 at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Tarsus Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tarsus Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataTARS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TARS Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Tarsus Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$0.82-$0.78-$0.80Q2 20253-$0.52-$0.45-$0.48Q3 20254-$0.32-$0.29-$0.31Q4 20253-$0.11-$0.05-$0.07FY 202513-$1.77-$1.57-$1.67Q1 20261-$0.06-$0.06-$0.06Q2 20261$0.32$0.32$0.32Q3 20261$0.56$0.56$0.56Q4 20261$0.80$0.80$0.80FY 20264$1.62$1.62$1.62 Tarsus Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/6/2025(Estimated)--------2/25/2025Q4 2024-$0.68-$0.60+$0.08-$0.60$58.80M$66.41M8/8/2024Q2 2024-$0.98-$0.88+$0.10-$0.88$31.30M$40.81M5/8/2024Q1 2024-$1.15-$1.01+$0.14-$1.01$17.94M$27.61M2/27/2024Q4 2023-$1.37-$1.31+$0.06-$1.31$4.63M$13.08M11/9/2023Q3 2023-$1.40-$1.28+$0.12-$1.28$0.72M$1.87M8/10/2023Q2 2023-$1.08-$1.17 -$0.09-$1.17--5/9/2023Q1 2023-$0.95-$0.88+$0.07-$0.88$3.33M$2.50M Tarsus Pharmaceuticals Earnings - Frequently Asked Questions When is Tarsus Pharmaceuticals's earnings date? Tarsus Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 6th, 2025 based off last year's report dates. Learn more on TARS's earnings history. Did Tarsus Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Tarsus Pharmaceuticals (NASDAQ:TARS) reported ($0.60) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.68) by $0.08. Learn more on analysts' earnings estimate vs. TARS's actual earnings. How can I listen to Tarsus Pharmaceuticals's earnings conference call? The conference call for Tarsus Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Tarsus Pharmaceuticals's conference call transcript? The conference call transcript for Tarsus Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Tarsus Pharmaceuticals generate each year? Tarsus Pharmaceuticals (NASDAQ:TARS) has a recorded annual revenue of $182.95 million. How much profit does Tarsus Pharmaceuticals generate each year? Tarsus Pharmaceuticals (NASDAQ:TARS) has a recorded net income of -$135.89 million. TARS has generated -$3.10 earnings per share over the last four quarters. What is Tarsus Pharmaceuticals's EPS forecast for next year? Tarsus Pharmaceuticals's earnings are expected to grow from ($3.17) per share to ($1.44) per share in the next year. More Earnings Resources from MarketBeat Related Companies Roivant Sciences Earnings Date Lantheus Earnings Date Revolution Medicines Earnings Date BridgeBio Pharma Earnings Date TG Therapeutics Earnings Date Legend Biotech Earnings Date Sarepta Therapeutics Earnings Date Blueprint Medicines Earnings Date Axsome Therapeutics Earnings Date Nuvalent Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Breaking Down Taiwan Semiconductor's Earnings and Future UpsideArcher Aviation Unveils NYC Network Ahead of Key Earnings ReportAlcoa’s Solid Earnings Don’t Make Tariff Math Easier for AA Stock3 Reasons to Like the Look of Amazon Ahead of EarningsTesla Stock Eyes Breakout With Earnings on DeckJohnson & Johnson Earnings Were More Good Than Bad—Time to Buy? Why Analysts Boosted United Airlines Stock Ahead of Earnings This page (NASDAQ:TARS) was last updated on 4/22/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrade War Just Turned 3 Unknown Stocks Into Rocket FuelThe Real Catalyst Behind America’s Next Bull Run One overlooked sector is being completely repriced — and s...Insiders Exposed | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tarsus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tarsus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
